October 2025
1. FILIPPI M, Rocca MA
   MS-STAT2: lessons from negative trials in multiple sclerosis.
   Lancet. 2025 Oct 1:S0140-6736(25)01673-3. doi: 10.1016/S0140-6736(25)01673.
   

   >> Share

   
   
2. CHATAWAY J, Williams T, Blackstone J, John N, et al
   Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
   Lancet. 2025 Oct 1:S0140-6736(25)01039-6. doi: 10.1016/S0140-6736(25)01039.
   

   >> Share

   
   November 2023
3. JAKIMOVSKI D, Bittner S, Zivadinov R, Morrow SA, et al
   Multiple sclerosis.
   Lancet. 2023 Nov 7:S0140-6736(23)01473-3. doi: 10.1016/S0140-6736(23)01473.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share